Lord, Abbett & Co
ETNB

Lord, Abbett & Co’s 89bio ETNB Stock Holding History

Lord, Abbett & Co’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-733,404
Closed -$5.33M – 537
2025
Q1 		$5.33M Buy
+733,404
New +$6.41M 0.02% 456
2023
Q4 		– Sell
-438,266
Closed -$6.77M – 537
2023
Q3 		$6.77M Sell
438,266
-399,376
-48% -$6.7M 0.03% 428
2023
Q2 		$15.9M Buy
837,642
+87,030
+12% +$1.53M 0.05% 381
2023
Q1 		$11.4M Buy
+750,612
New +$9.79M 0.04% 400

Other funds holding ETNB

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lord, Abbett & Co's ETNB Position: Q2 2025 in Review

Lord, Abbett & Co sold out of 89bio (ETNB) in Q2 2025, closing a stake of 733,404 shares — an estimated $5.33M sold.

Lord, Abbett & Co first reported a position in ETNB in Q1 2023 and held it in 4 quarters. The position peaked at $15.9M in Q2 2023. 184 funds tracked by Wall St. Rank hold ETNB as of Q2 2025.

  • Lord, Abbett & Co reported no remaining 89bio position as of Q2 2025 after selling out during the quarter.
  • Lord, Abbett & Co sold 733,404 89bio shares in Q2 2025, an estimated $5.33M.
  • Lord, Abbett & Co first reported a position in 89bio in Q1 2023 and held it in 4 quarters.
  • Lord, Abbett & Co's 89bio position peaked at $15.9M in Q2 2023.
  • 184 funds tracked by Wall St. Rank held 89bio as of Q2 2025.

Based on Lord, Abbett & Co's 13F filing for Q2 2025, filed 14 Aug 2025.